Literature DB >> 22648868

Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.

Yvonne E Chiu1, Beth A Drolet, Francine Blei, Manuel Carcao, Jason Fangusaro, Michael E Kelly, Alfons Krol, Sabra Lofgren, Anthony J Mancini, Denise W Metry, Michael Recht, Robert A Silverman, Wynnis L Tom, Elena Pope.   

Abstract

Propranolol is a non-selective beta-adrenergic antagonist successfully used in a case of kaposiform hemangioendothelioma (KHE) associated with Kasabach-Merritt phenomenon (KMP). We report 11 patients treated with propranolol for KHE and the related variant tufted angioma (TA), six of whom also had KMP. The varied responses to treatment, with only 36% responding in our series, demonstrate the need for further study of this medication before routine use for these indications.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22648868      PMCID： PMC3528889          DOI： 10.1002/pbc.24103

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


  12 in total

1.  Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment.

Authors:  Denise Josephina Johanna Hermans; Ingrid Mathilde van Beynum; Rozemarijn Junelle van der Vijver; Leonardus Jan Schultze Kool; Ivo de Blaauw; Catharina Joanna Maria van der Vleuten
Journal:  J Pediatr Hematol Oncol       Date:  2011-05       Impact factor: 1.289

Review 2.  Kasabach-Merritt phenomenon.

Authors:  Michael Kelly
Journal:  Pediatr Clin North Am       Date:  2010-08-21       Impact factor: 3.278

3.  Propranolol for severe hemangiomas of infancy.

Authors:  Christine Léauté-Labrèze; Eric Dumas de la Roque; Thomas Hubiche; Franck Boralevi; Jean-Benoît Thambo; Alain Taïeb
Journal:  N Engl J Med       Date:  2008-06-12       Impact factor: 91.245

4.  Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas.

Authors:  O Enjolras; M Wassef; E Mazoyer; I J Frieden; P N Rieu; L Drouet; A Taïeb; J F Stalder; J P Escande
Journal:  J Pediatr       Date:  1997-04       Impact factor: 4.406

5.  Treatment of childhood kaposiform hemangioendothelioma with sirolimus.

Authors:  Julie Blatt; Joseph Stavas; Billie Moats-Staats; John Woosley; Dean S Morrell
Journal:  Pediatr Blood Cancer       Date:  2010-12-15       Impact factor: 3.167

6.  Tufted angiomas: variability of the clinical morphology.

Authors:  Mark D Herron; Cheryl M Coffin; Sheryll L Vanderhooft
Journal:  Pediatr Dermatol       Date:  2002 Sep-Oct       Impact factor: 1.588

7.  Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis.

Authors:  L R Zukerberg; B J Nickoloff; S W Weiss
Journal:  Am J Surg Pathol       Date:  1993-04       Impact factor: 6.394

8.  Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma.

Authors:  Lisa L Lyons; Paula E North; Fernand Mac-Moune Lai; Mark H Stoler; Andrew L Folpe; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2004-05       Impact factor: 6.394

Review 9.  Kaposiform hemangioendothelioma.

Authors:  Y Fernández; M Bernabeu-Wittel; J S García-Morillo
Journal:  Eur J Intern Med       Date:  2008-08-15       Impact factor: 4.487

10.  Tufted angioma (angioblastoma). A benign progressive angioma, not to be confused with Kaposi's sarcoma or low-grade angiosarcoma.

Authors:  E W Jones; M Orkin
Journal:  J Am Acad Dermatol       Date:  1989-02       Impact factor: 11.527
View more
  28 in total

Review 1.  Advances in the Medical Management of Vascular Anomalies.

Authors:  Kiersten W Ricci
Journal:  Semin Intervent Radiol       Date:  2017-09-11       Impact factor: 1.513

2.  Multimodal treatment of Kasabach-Merritt syndrome arising from tufted angioma: A case report.

Authors:  Run-Song Jiang; Zheng-Yan Zhao
Journal:  Oncol Lett       Date:  2017-04-20       Impact factor: 2.967

Review 3.  Tufted angiomas of the head and neck.

Authors:  S M Häußler; F C Uecker; S Knopke; F Roßner; H Olze; A Böttcher
Journal:  HNO       Date:  2018-01       Impact factor: 1.284

4.  Kaposiform Hemangioendothelioma in a 3 Months Old Infant.

Authors:  Ramya Uppuluri; Vimal Kumar; Deenadayalan Munirathnam; Hemalatha Doss; Sreejith Ramachandrakurup; Divya Subburaj; Revathi Raj
Journal:  Indian J Hematol Blood Transfus       Date:  2016-04-08       Impact factor: 0.900

5.  Medical therapy for pediatric vascular anomalies.

Authors:  Judith F Margolin; Heather Mills Soni; Sheena Pimpalwar
Journal:  Semin Plast Surg       Date:  2014-05       Impact factor: 2.314

6.  GNA14 Somatic Mutation Causes Congenital and Sporadic Vascular Tumors by MAPK Activation.

Authors:  Young H Lim; Antonella Bacchiocchi; Jingyao Qiu; Robert Straub; Anna Bruckner; Lionel Bercovitch; Deepak Narayan; Jennifer McNiff; Christine Ko; Leslie Robinson-Bostom; Richard Antaya; Ruth Halaban; Keith A Choate
Journal:  Am J Hum Genet       Date:  2016-07-28       Impact factor: 11.025

7.  Clinicopathological features of Kaposiform hemangioendothelioma.

Authors:  Qiuyu Liu; Lili Jiang; Danting Wu; Yunzhen Kan; Fangfang Fu; Dongyi Zhang; Yubin Gong; Ying Wang; Changxian Dong; Lingfei Kong
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

8.  Kasabach-Merritt syndrome combined with hypercalcemia: A case report.

Authors:  Runying Zou; Fang Peng; Tian Yu; Saizhen Zeng; Yalan You; Keke Chen; Hui Zou; Xin Tian; Chengguang Zhu; Xiangling He
Journal:  Exp Ther Med       Date:  2017-10-18       Impact factor: 2.447

9.  Clinical and imaging features of Kaposiform Hemangioendothelioma.

Authors:  Pei-An Hu; Zheng-Rong Zhou
Journal:  Br J Radiol       Date:  2018-03-20       Impact factor: 3.039

Review 10.  Standards of care for Kasabach-Merritt phenomenon in China.

Authors:  Wei Yao; Ke-Lei Li; Zhong-Ping Qin; Kai Li; Jia-Wei Zheng; Xin-Dong Fan; Lin Ma; De-Kai Zhou; Xue-Jian Liu; Li Wei; Li Li; Mao-Zhong Tai; Jin-Hu Wang; Yi Ji; Lin Zhou; Hai-Jin Huang; Xiao-Yun Gao; Zhi-Jian Huang; Song Gu; He-Ying Yang
Journal:  World J Pediatr       Date:  2020-08-26       Impact factor: 2.764
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.